Meta Materials Inc (NASDAQ: MMAT) has reached the tail-end of a 27-month long project focused on developing a non-invasive glucose sensing prototype. The latest innovation functions on the principle of combining optical sensors and radio waves to advance accuracy in the prediction of glucose level changes.
The project’s design
The company is quite pleased with its biosensing prototype. It has been quick to term it a crucial step in developing a “Home Hub” system to monitor biological parameters.
The UK government-funded the project through Innovate UK, channeling about £911K (US$1.25M) into the project. The collaborative move happened in the UK, and four partners participated. They included the Brunel Innovation Centre, The Imagination Factory, Virtual Clinic Direct, and META through Medical Wireless Sensing Ltd., Which happens to be its wholly-owned UK subsidiary.
The project entailed developing several prototypes of the system meant for diabetes patients. However, the persons under closer focus included the patients in the point of care settings such as homes and clinics.
The system in question was constituted by a “Home Hub” consisting of a wearable element to facilitate overnight trend monitoring. The other thing is that the system employs a multiwavelength biosensing technology that utilizes both the optical and radio wave sensors in its functionality. The other functionality attribute of the system is the use of machine learning processing.
The project ran successfully and could use some particular inferences in several ways. For example, the studies indicated that the system led to greater accuracy in predicting glucose level changes, something quite different from the standalone sensors.
Kallos speaks out about the project
The Co-Founder and Chief Science Officer of META Themos Kallos opined, “Accurately measuring glucose without drawing blood must overcome a number of challenges, including the weak signature of the glucose molecule compared to other tissue components and water, the signal interference from other biological substances, calibrating for the effects of environmental factors such as ambient temperature and skin moisture.”